Preetam Shah

2022

In 2022, Preetam Shah earned a total compensation of $683.7K as Chief Financial Officer and Chief Business Officer at Cidara Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$151,300
Option Awards$54,028
Salary$417,400
Stock Awards$51,836
Other$9,150
Total$683,714

Shah received $417.4K in salary, accounting for 61% of the total pay in 2022.

Shah also received $151.3K in non-equity incentive plan, $54K in option awards, $51.8K in stock awards and $9.2K in other compensation.

Rankings

In 2022, Preetam Shah's compensation ranked 3,818th out of 5,753 executives tracked by ExecPay. In other words, Shah earned more than 33.6% of executives.

ClassificationRankingPercentile
All
3,818
out of 5,753
34th
Division
Manufacturing
2,160
out of 3,133
31st
Major group
Chemicals And Allied Products
1,041
out of 1,419
27th
Industry group
Drugs
977
out of 1,320
26th
Industry
Biological Products, Except Diagnostic Substances
229
out of 291
21st
Source: SEC filing on April 27, 2023.

Shah's colleagues

We found two more compensation records of executives who worked with Preetam Shah at Cidara Therapeutics in 2022.

2022

Jeffrey Stein

Cidara Therapeutics

Chief Executive Officer

2022

Taylor Sandison

Cidara Therapeutics

Chief Medical Officer

News

You may also like